NO850817L - Fremgangsmaate for aa bevare effektiviteten til bakteriepreparater - Google Patents
Fremgangsmaate for aa bevare effektiviteten til bakteriepreparaterInfo
- Publication number
- NO850817L NO850817L NO850817A NO850817A NO850817L NO 850817 L NO850817 L NO 850817L NO 850817 A NO850817 A NO 850817A NO 850817 A NO850817 A NO 850817A NO 850817 L NO850817 L NO 850817L
- Authority
- NO
- Norway
- Prior art keywords
- effectiveness
- keeping
- procedure
- bakery
- preparations
- Prior art date
Links
- 238000000034 method Methods 0.000 title 1
- 238000002360 preparation method Methods 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/095—Sulfur, selenium, or tellurium compounds, e.g. thiols
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
- A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/20—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing sulfur, e.g. dimethyl sulfoxide [DMSO], docusate, sodium lauryl sulfate or aminosulfonic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Mycology (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Molecular Biology (AREA)
- Microbiology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Bakery Products And Manufacturing Methods Therefor (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FI840816A FI840816A0 (fi) | 1984-03-01 | 1984-03-01 | Bakteriepreparat |
Publications (3)
Publication Number | Publication Date |
---|---|
NO850817L true NO850817L (no) | 1985-09-02 |
NO165744B NO165744B (no) | 1990-12-27 |
NO165744C NO165744C (no) | 1991-04-10 |
Family
ID=8518638
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO850817A NO165744C (no) | 1984-03-01 | 1985-02-28 | Fremgangsmaate for aa bevare virkningen av bakteriepreparater hvor bakteriene har sin opprinnelse fra tarmen til friske fjaerkre. |
Country Status (10)
Country | Link |
---|---|
US (1) | US4657762A (no) |
EP (1) | EP0154478A3 (no) |
JP (1) | JPH0759516B2 (no) |
AU (1) | AU581198B2 (no) |
CA (1) | CA1236400A (no) |
DK (1) | DK70385A (no) |
ES (1) | ES8605375A1 (no) |
FI (1) | FI840816A0 (no) |
NO (1) | NO165744C (no) |
ZA (1) | ZA85324B (no) |
Families Citing this family (39)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4910024A (en) * | 1988-07-05 | 1990-03-20 | Micro Chemical, Inc. | Method and apparatus for administering live bacteria as feed additives to livestock and poultry |
US5443826A (en) * | 1988-08-02 | 1995-08-22 | Borody; Thomas J. | Treatment of gastro-intestinal disorders with a fecal composition or a composition of bacteroides and E. Coli |
EP0433299B1 (en) * | 1988-08-02 | 1998-05-06 | Gastro Services Pty. Limited (ACN 002 994 890) | Treatment of gastro-intestinal disorders |
US5206015A (en) * | 1989-06-05 | 1993-04-27 | The United States Of America As Represented By The Secretary Of Agriculture | Introduction of bacteria in ovo |
GB2233343B (en) * | 1989-06-30 | 1993-07-07 | Farmos Oy | A bacterial preparation for use in poultry |
US5139792A (en) * | 1990-07-19 | 1992-08-18 | Bio-Techniques Laboratories, Inc. | Method and system for dispensing live bacteria into animal feed and drinking water |
US5179020A (en) * | 1991-08-19 | 1993-01-12 | Bio Techniques Laboratories, Inc. | Antibiotic resistant strain of lactobacillus acidophilus |
US5256425A (en) * | 1991-08-19 | 1993-10-26 | Bio Techniques Laboratories, Inc. | Antibiotic resistant strain of lactobacillus acidophilus |
US5302388A (en) * | 1991-11-13 | 1994-04-12 | Wisconsin Alumni Research Foundation | Control of campylobacter jejuni colonization |
DK0689381T3 (da) * | 1993-03-16 | 2000-04-17 | Us Agriculture | Mucosal kompetitiv udelukkelsesflora |
ATE237678T1 (de) * | 1994-07-29 | 2003-05-15 | Us Agriculture | Saccharomyces-behandlung zur verringerung von campylobakter- und salmonella-populationen in geflügel |
US5722342A (en) * | 1996-06-28 | 1998-03-03 | Us Agriculure | Ovo antibiotic and microbial treatment to dimenish salmonellae populations in avians |
US5807546A (en) * | 1996-10-11 | 1998-09-15 | The United States Of America As Represented By The Secretary Of Agriculture | Livestock mucosal competitive exclusion culture to reduce enteropathogenic bacteria |
AT407008B (de) * | 1998-08-06 | 2000-11-27 | Viernstein Helmut Dr | Formulierungen mit probiotisch wirksamen mikroorganismen |
AUPQ899700A0 (en) | 2000-07-25 | 2000-08-17 | Borody, Thomas Julius | Probiotic recolonisation therapy |
US20040241150A1 (en) * | 2002-12-19 | 2004-12-02 | Hargis Billy M. | Defined competitive exclusion cultures for food borne pathogens |
WO2006101486A2 (en) | 2005-03-18 | 2006-09-28 | The United States Of America, As Represented By The Secretary Of Agriculture | Bacteriocins and novel bacterial strains |
EP2351494A1 (en) | 2005-03-18 | 2011-08-03 | The United States of America as represented by the secretary of Agriculture | Bacteriocins and novel bacterial strains |
BR112013001107B1 (pt) | 2010-07-16 | 2022-01-25 | The Board Of Trustees Of The University Of Arkansas | Métodos e composições incluindo bactéria formadora de esporos para aumento da saúde dos animais |
CA2807242C (en) | 2010-08-04 | 2017-05-02 | Thomas Julius Borody | Compositions for fecal floral transplantation and methods for making and using them and devices for delivering them |
WO2012044984A1 (en) | 2010-09-30 | 2012-04-05 | The Board Of Trustees Of The University Of Arkansas | Methods of selecting and using therapeutic and prophylactic probiotic cultures to reduce bacterial pathogen loads |
SG193348A1 (en) | 2011-03-09 | 2013-10-30 | Univ Minnesota | Compositions and methods for transplantation of colon microbiota |
US9719144B2 (en) | 2012-05-25 | 2017-08-01 | Arizona Board Of Regents | Microbiome markers and therapies for autism spectrum disorders |
US9393275B2 (en) | 2012-08-01 | 2016-07-19 | Novozymes A/S | Probiotic for amelioration of coccidiosis vaccine reaction |
EP3632214A1 (en) | 2013-06-20 | 2020-04-08 | Mars, Incorporated | Performance pet food product |
JP6692897B2 (ja) | 2015-05-14 | 2020-05-13 | クレストヴォ・ホールディングス・エルエルシー | 便フローラを移植するための組成物、並びにそれを調製及び使用する方法、並びにそれを送達するためのデバイス |
AU2016268158B2 (en) | 2015-05-22 | 2022-03-17 | Arizona Board Of Regents On Behalf Of Arizona State University | Methods for treating autism spectrum disorder and associated symptoms |
US20170360848A1 (en) | 2016-06-15 | 2017-12-21 | Arizona Board Of Regents On Behalf Of Arizona State University | Methods for treating autism spectrum disorder and associated symptoms |
US10849936B2 (en) | 2016-07-01 | 2020-12-01 | Regents Of The University Of Minnesota | Compositions and methods for C. difficile treatment |
US20180036352A1 (en) | 2016-08-03 | 2018-02-08 | Crestovo Holdings Llc | Methods for treating ulcerative colitis |
WO2018071536A1 (en) | 2016-10-11 | 2018-04-19 | Crestovo Holdings Llc | Compositions and methods for treating primary sclerosing cholangitis and related disorders |
US10092601B2 (en) | 2016-10-11 | 2018-10-09 | Crestovo Holdings Llc | Compositions and methods for treating multiple sclerosis and related disorders |
WO2018071537A1 (en) | 2016-10-11 | 2018-04-19 | Crestovo Holdings Llc | Compositions and methods for treating multiple sclerosis and related disorders |
WO2018187467A1 (en) | 2017-04-05 | 2018-10-11 | Crestovo Holdings Llc | Compositions and methods for treating parkinson's disease (pd) and related disorders |
WO2018187464A1 (en) | 2017-04-05 | 2018-10-11 | Crestovo Holdings Llc | Compositions and methods for treating diverticulitis and related disorders |
CA3064773A1 (en) | 2017-05-26 | 2018-11-29 | Crestovo Holdings Llc | Lyophilized compositions comprising fecal microbe-based therapeutic agents and methods for making and using same |
WO2019032573A1 (en) | 2017-08-07 | 2019-02-14 | Finch Therapeutics, Inc. | COMPOSITIONS AND METHODS FOR MAINTAINING AND RESTORING A HEALTHY INTESTINAL BARRIER |
US11166990B2 (en) | 2018-07-13 | 2021-11-09 | Finch Therapeutics Holdings Llc | Methods and compositions for treating ulcerative colitis |
JP2022514145A (ja) | 2018-09-27 | 2022-02-10 | フィンチ セラピューティクス ホールディングス エルエルシー | てんかんおよび関連する障害を治療するための組成物および方法 |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3953609A (en) * | 1974-02-06 | 1976-04-27 | Microlife Technics, Inc. | Method for the growth restriction of undesirable digestive system bacteria in animals and the establishment of lactobacillus lactis NRRL B-5628 |
US4030978A (en) * | 1976-07-29 | 1977-06-21 | Becton, Dickinson And Company | Novel assembly, compositions and methods |
JPS54143585A (en) * | 1978-04-28 | 1979-11-08 | Kyowa Hakko Kogyo Co Ltd | Culturing of microbials and storing of freeze-dried microbial cells |
US4335107A (en) * | 1978-06-05 | 1982-06-15 | Snoeyenbos Glenn H | Mixture to protect poultry from salmonella |
FI59925C (fi) * | 1980-01-11 | 1981-11-10 | Esko Viljo Nurmi | Foerfarande foer framstaellning av ett bakteriepreparat anvaendbart foer foerhindrande av salmonellainfektion hos fjaederfae |
US4251509A (en) * | 1980-01-31 | 1981-02-17 | Wisconsin Alumni Research Foundation | Dry particulate vaccine for oral administration |
-
1984
- 1984-03-01 FI FI840816A patent/FI840816A0/fi not_active Application Discontinuation
-
1985
- 1985-01-08 CA CA000471660A patent/CA1236400A/en not_active Expired
- 1985-01-10 AU AU37580/85A patent/AU581198B2/en not_active Ceased
- 1985-01-15 ZA ZA85324A patent/ZA85324B/xx unknown
- 1985-02-13 ES ES540375A patent/ES8605375A1/es not_active Expired
- 1985-02-15 DK DK70385A patent/DK70385A/da not_active Application Discontinuation
- 1985-02-25 US US06/705,255 patent/US4657762A/en not_active Expired - Lifetime
- 1985-02-25 EP EP85301242A patent/EP0154478A3/en not_active Withdrawn
- 1985-02-28 NO NO850817A patent/NO165744C/no unknown
- 1985-02-28 JP JP60040280A patent/JPH0759516B2/ja not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
ZA85324B (en) | 1985-08-28 |
JPS60202823A (ja) | 1985-10-14 |
AU3758085A (en) | 1985-09-05 |
AU581198B2 (en) | 1989-02-16 |
ES8605375A1 (es) | 1986-03-16 |
JPH0759516B2 (ja) | 1995-06-28 |
DK70385D0 (da) | 1985-02-15 |
NO165744C (no) | 1991-04-10 |
FI840816A0 (fi) | 1984-03-01 |
NO165744B (no) | 1990-12-27 |
EP0154478A3 (en) | 1987-06-10 |
EP0154478A2 (en) | 1985-09-11 |
CA1236400A (en) | 1988-05-10 |
US4657762A (en) | 1987-04-14 |
ES540375A0 (es) | 1986-03-16 |
DK70385A (da) | 1985-09-02 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO850817L (no) | Fremgangsmaate for aa bevare effektiviteten til bakteriepreparater | |
NO166865C (no) | Analogifremgangsmaate til fremstilling av terapeutisk aktive o-glykosidforbindelser. | |
RO86213A (ro) | Procedeu pentru prepararea izobutenei | |
NO864879D0 (no) | Fremgangsmaate for fremstilling av terapeutisk aktive tiasolforbindelser. | |
NO864110L (no) | Fremgangsmaate for fremstilling av terapeutisk virksomme benzimidazolderivater. | |
DK474585D0 (da) | Fremgangsmaade til mikroindkapsling | |
NO832022L (no) | Fremgangsmaate til fremstilling av amidiner | |
IT1176332B (it) | Procedimento per al preparazione di peptidi | |
NO862141L (no) | Fremgangsmaate for fremstilling av aktive cinnolinderivater | |
NO164295C (no) | Analogifremgangsmaate til fremstilling av terapeutisk aktive fluorerte benzyltriazolforbindelser. | |
NO163775C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive isoindolinyl-alkyl-piperaziner. | |
NO861584L (no) | Fremgangsmaate til fremstilling av terapeutisk aktive cyklopentyletere. | |
NO169126C (no) | Fremgangsmaate for fremstilling av n-formyl-alfa-aspartyl-fenylalanin | |
IT8521570A0 (it) | Procedimento di preparazione di microlattici invertiti ed i microlattici invertiti ottenuti. | |
NO853066L (no) | Fremgansmaate til fremstilling av 3-karbonyl-1-aminoalkyl-1h-indoler. | |
IT8567535A0 (it) | Procedimento per la preparazione di amminoidrossicefamcarbossilati | |
NO162188C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive imidazokinoliner. | |
NO169441C (no) | Fremgangsmaate til fremstilling av 7-oksomitosanderivater | |
NO168581C (no) | Fremgangsmaate ved fremstilling av terapeutisk aktive beta-methylen-thiofenethanaminer | |
ES545117A0 (es) | Procedimiento de preparacion de nuevos derivados de acido- 9- u 11-nitroaprovincaminico racemicos y opticamente activos | |
NO863769D0 (no) | Fremgangsmaate for fremstilling av 4-hydroksy-2-oksopyrrolin-1-yl-acetamid. | |
NO161353C (no) | Fremgangsmaate for fremstilling av pastiller. | |
DK357685A (da) | Fremgangsmaade til makrolid alkylering | |
NO168473C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive fenylthiazoloner. | |
NO830685L (no) | Fremgangsmaate for fremstilling av antidiabetiske preparater |